Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis

by Pierpaolo Trimboli, Luca Giovanella
Published 2018-06-01

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls

by Carolien M. Beukhof, Tessa Brabander, Francien H. van Nederveen, Marie-Louise F. van Velthuysen, Yolanda B. de Rijke, Leo J. Hofland, Gaston J. H. Franssen, Lideke A. C. Fröberg, Boen L. R. Kam, W. Edward Visser, Wouter W. de Herder, Robin P. Peeters
Published 2019-04-01

Recent Updates on the Management of Medullary Thyroid Carcinoma

by Bo Hyun Kim, In Joo Kim
Published 2016-09-01